Eli Lilly and Company
Anti-IL-33 antibodies and uses thereof for disease treatment
Last updated:
Abstract:
Antibodies which bind and neutralize human IL-33, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with allergic disease including treating atopic dermatitis.
Status:
Grant
Type:
Utility
Filling date:
24 Oct 2017
Issue date:
10 Dec 2019